MOLECULAR MARKERS OF HEMOSTATIC PROCESSES - IMPLICATIONS IN DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF THROMBOTIC AND HEMORRHAGIC DISORDERS

被引：0
|
作者：
BICK, RL
FAREED, J
SQUILLACI, G
WALENGA, J
BERMES, EW
MESSMORE, HL
机构：
[1] LOYOLA UNIV,MED CTR,MAYWOOD,IL 60153
[2] SAN JOAQUIN HEMATOL & ONCOL GRP,BAKERSFIELD,CA 93305
来源：
FEDERATION PROCEEDINGS | 1983年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1031 / 1031
页数：1
相关论文
共 50 条
  • [1] MOLECULAR MARKERS OF HEMOSTATIC DISORDERS - IMPLICATIONS IN THE DIAGNOSIS AND THERAPEUTIC MANAGEMENT OF THROMBOTIC AND BLEEDING DISORDERS
    FAREED, J
    BICK, RL
    SQUILLACI, G
    WALENGA, JM
    BERMES, EW
    CLINICAL CHEMISTRY, 1983, 29 (09) : 1641 - 1658
  • [2] Molecular markers of hemostatic activation: Applications in the diagnosis of thrombosis and vascular and thrombotic disorders
    Fareed, J
    Bick, RL
    Hoppensteadt, DA
    Bermes, EW
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1995, 1 (02) : 87 - 102
  • [3] MOLECULAR MARKERS OF HEMOSTATIC DISORDERS - PREFACE
    FAREED, J
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (04): : R5 - R6
  • [4] Molecular markers of hemostatic and vascular abberations in the elderly and their predictive value for the diagnosis of thrombotic disorders.
    Iqbal, O
    Hoppensteadt, DA
    Koza, MJ
    Bermes, EW
    Walenga, JM
    Fareed, J
    CLINICAL CHEMISTRY, 1996, 42 (06) : 413 - 413
  • [5] MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS
    FAREED, J
    BICK, RL
    HOPPENSTEADT, DA
    WALENGA, JM
    MESSMORE, HL
    BERMES, EW
    CLINICS IN LABORATORY MEDICINE, 1995, 15 (01) : 39 - 61
  • [6] PROFILE DIAGNOSIS OF HEMOSTATIC DISORDERS BY SIMULTANEOUS ASSAY OF HEMOSTATIC MOLECULAR MARKERS
    TERUYA, J
    SHIMIZU, N
    MATSUDA, J
    KAZAMA, M
    ABE, T
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 74 - 74
  • [7] DIAGNOSTIC AND THERAPEUTIC ASPECTS OF PLATELET-DEPENDENT HEMOSTATIC DISORDERS
    NOLTE, I
    MISCHKE, R
    AMMELOUNX, U
    NIEMAND, C
    HEYDE, PM
    KLEINTIERPRAXIS, 1994, 39 (10): : 709 - &
  • [8] Hemostatic Disorders: Clinical Management Based on Molecular Mechanisms
    Scharf, R. E.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (03) : 171 - 185
  • [9] Differential inhibition of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins. Therapeutic implications in the management of thrombotic disorders.
    Florian, M
    Hoppnsteadt, D
    Tobu, M
    Iqbal, O
    Fareed, J
    BLOOD, 2002, 100 (11) : 131B - 132B
  • [10] Utilization of clinical diagnostic exome sequencing for the molecular diagnosis of mitochondrial disorders and therapeutic implications
    Tang, Sha
    Gonzalez, Kelly D. F.
    Zeng, Wenqi
    Shahmirzadi, Layla
    Wei, Jennifer J.
    Li, Xiang
    Chao, Elizabeth C.
    MITOCHONDRION, 2013, 13 (06) : 919 - 920
12345